Divaya Bhutani

Columbia University Irving Medical Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Selinexor in Combination with R-CHOP for Frontline Treatment of Non-Hodgkin Lymphoma: Results of a Phase I Study”.

Selinexor in Combination with R-CHOP for Frontline Treatment of Non-Hodgkin Lymphoma: Results of a Phase I Study

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4929

N/A

0.953DataRank · unranked

25 citations

Husain Yar Khan, Yiwei Li, Mahmoud Chaker, Irfana Muqbil, Amro Aboukameel +18 more

A Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance

Cancer Cell(2020)10.1016/j.ccell.2020.10.022

N/A

0DataRank · unranked

33 citations

David M. Aboulafia, Melissa Accordino, Jared D. Acoba, Manmeet S. Ahluwalia, Syed A. Ahmad +95 more

Use of daratumumab in high risk multiple myeloma: A meta‐analysis

eJHaem(2020)10.1002/jha2.47

N/A

0DataRank · unranked

26 citations

Samuel Pan, Suzanne Lentzsch, Divaya Bhutani, Vikram Premkumar

Venetoclax induces deep hematologic remissions in t(11;14) relapsed/refractory AL amyloidosis

Blood Cancer Journal(2021)10.1038/s41408-020-00397-w

N/A

0DataRank · unranked

110 citations

Suzanne Lentzsch, Samuel Pan, Divaya Bhutani, Joshua Richter, Sundar Jagannath +13 more

Dual targeting of protein translation and nuclear protein export results in enhanced antimyeloma effects

Blood Advances(2023)10.1182/bloodadvances.2021006638

N/A

0DataRank · unranked

15 citations

Jing Fu, Christopher J. Walker, Jun Yang, Divaya Bhutani, Rajshekhar Chakraborty +5 more

Data from Selinexor in Combination with R-CHOP for Frontline Treatment of Non-Hodgkin Lymphoma: Results of a Phase I Study

(2023)10.1158/1078-0432.c.6530103

N/A

0DataRank · unranked

0 citations

Husain Yar Khan, Yiwei Li, Mahmoud Chaker, Irfana Muqbil, Amro Aboukameel +18 more

Data from Selinexor in Combination with R-CHOP for Frontline Treatment of Non-Hodgkin Lymphoma: Results of a Phase I Study

(2023)10.1158/1078-0432.c.6530103.v1

N/A

0DataRank · unranked

0 citations

Husain Yar Khan, Yiwei Li, Mahmoud Chaker, Irfana Muqbil, Amro Aboukameel +18 more

Safety and Efficacy of SGLT2 Inhibitors for Amyloid Light-Chain Cardiomyopathy

Journal of Cardiac Failure(2024)10.1016/j.cardfail.2024.06.009

N/A

0DataRank · unranked

18 citations

Sergio Teruya, Margaret Cuomo, Alfonsina Mirabal Santos, Jai Radhakrishnan, Suzanne Lentzsch +4 more

GCK inhibition enhances iberdomide antimyeloma effects by promoting IKZF1 degradation via a CRBN-independent mechanism

Blood Neoplasia(2025)10.1016/j.bneo.2025.100130

N/A

0DataRank · unranked

1 citations

Josefine Krüger, Guifen Liu, Huihui Ma, Michael Sang Hughes, Rajshekhar Chakraborty +6 more

Targeting the GCK pathway: a novel and selective therapeutic strategy against RAS-mutated multiple myeloma

Blood(2020)10.1182/blood.2020006334

N/A

0DataRank · unranked

18 citations

Jing Fu, Jun Yang, Huihui Ma, Divaya Bhutani, Markus Y. Mapara +3 more

Proteinuria with preserved renal function (PPRF): A retrospective cohort study in newly diagnosed multiple myeloma.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.e19559

N/A

0DataRank · unranked

0 citations

Metodi Balev, Jai Radhakrishnan, Divaya Bhutani, Markus Y. Mapara, Suzanne Lentzsch +3 more